Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Jul 16;18(3):700–709.e3. doi: 10.1016/j.cgh.2019.07.018

Figure 2a:

Figure 2a:

Prior Treatment History and Course of Patients with Spontaneous HBsAg Loss. *Patient received adefovir for 5 years and then discontinued treatment 7 years prior to initiating care at NIH. Patient received entecavir for 3 years and then discontinued therapy before initiating care at NIH.